{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:35:24Z","timestamp":1765233324777,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cca.2022.06.011","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T02:04:06Z","timestamp":1655345046000},"page":"48-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Application of cerebrospinal fluid free light chain in diagnosis of primary central nervous system lymphoma and monitoring of associated chemotherapy efficacy"],"prefix":"10.1016","volume":"533","author":[{"given":"Yao","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2022.06.011_b0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.hoc.2016.07.001","article-title":"Molecular classification of diffuse large B-cell lymphoma: what is clinically relevant?","volume":"30","author":"Sujobert","year":"2016","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"9","key":"10.1016\/j.cca.2022.06.011_b0010","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1586\/14737140.2013.829634","article-title":"Recurrent or refractory primary central nervous lymphoma: therapeutic considerations","volume":"13","author":"Dahiya","year":"2013","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.cca.2022.06.011_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-017-0064-3","article-title":"Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease","volume":"14","author":"Ambady","year":"2017","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.cca.2022.06.011_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-006-9165-6","article-title":"Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors","volume":"80","author":"Jahnke","year":"2006","journal-title":"J. Neurooncol."},{"issue":"22","key":"10.1016\/j.cca.2022.06.011_b0025","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/cncr.30965","article-title":"Diagnosis and management of primary central nervous system lymphoma","volume":"123","author":"Han","year":"2017","journal-title":"Cancer"},{"issue":"1-2","key":"10.1016\/j.cca.2022.06.011_b0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000475530","article-title":"Tumor heterogeneity in lymphomas: a different breed","volume":"85","author":"Sch\u00fcrch","year":"2018","journal-title":"Pathobiology"},{"issue":"8","key":"10.1016\/j.cca.2022.06.011_b0035","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.2005.04.8819","article-title":"Primary CNS lymphoma","volume":"24","author":"Batchelor","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2022.06.011_b0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1309\/AJCP4INKZ6LYAQXW","article-title":"Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review","volume":"137","author":"Charafeddine","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.cca.2022.06.011_b0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.trsl.2006.11.001","article-title":"Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"149","author":"Martin","year":"2007","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.cca.2022.06.011_b0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0609.2010.01475.x","article-title":"Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas","volume":"85","author":"Schroers","year":"2010","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.cca.2022.06.011_b0055","unstructured":"S. Swerdlow, F. Berger, WHO classification of tumors of hematopoietic and lymphoid tissues. 2008."},{"key":"10.1016\/j.cca.2022.06.011_b0060","article-title":"Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma","author":"Zhuang","year":"2019","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.cca.2022.06.011_b0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.hoc.2005.05.009","article-title":"Clinical features and diagnosis of primary central nervous system lymphoma","volume":"19","author":"Fitzsimmons","year":"2005","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.cca.2022.06.011_b0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hon.2489","article-title":"The use of droplet digital PCR in liquid biopsies: a highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid","volume":"36","author":"Hiemcke-Jiwa","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2022.06.011_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-7-185","article-title":"Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study","volume":"7","author":"Hildebrandt","year":"2007","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.cca.2022.06.011_b0080","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1373\/clinchem.2004.033977","article-title":"Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis","volume":"50","author":"Fischer","year":"2004","journal-title":"Clin. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122011949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122011949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:04:48Z","timestamp":1757862288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122011949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":16,"alternative-id":["S0009898122011949"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.06.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of cerebrospinal fluid free light chain in diagnosis of primary central nervous system lymphoma and monitoring of associated chemotherapy efficacy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}